<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billNumber>5554</billNumber>
    <createDate>2018-04-19T07:10:54Z</createDate>
    <updateDate>2021-07-10T20:12:25Z</updateDate>
    <originChamber>House</originChamber>
    <billType>HR</billType>
    <introducedDate>2018-04-18</introducedDate>
    <congress>115</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 164, Number 63 (Wednesday, April 18, 2018)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. MULLIN:H.R. 5554.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 3 of the United StatesConstitution.[Page H3442]</pre>]]></constitutionalAuthorityStatementText>
    <recordedVotes />
    <committees>
      <billCommittees>
        <item>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
          <chamber>House</chamber>
          <type>Standing</type>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <name>Health Subcommittee</name>
              <activities>
                <item>
                  <name>Reported by</name>
                  <date>2018-04-25T20:34:03Z</date>
                </item>
                <item>
                  <name>Markup by</name>
                  <date>2018-04-25T15:44:54Z</date>
                </item>
                <item>
                  <name>Referred to</name>
                  <date>2018-04-25T15:37:59Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
          <activities>
            <item>
              <name>Markup by</name>
              <date>2018-05-09T15:47:19Z</date>
            </item>
            <item>
              <name>Referred to</name>
              <date>2018-04-18T14:02:00Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <committeeReports />
    <relatedBills>
      <item>
        <latestTitle>Animal Drug and Animal Generic Drug User Fee Amendments of 2018</latestTitle>
        <congress>115</congress>
        <number>2434</number>
        <type>S</type>
        <latestAction>
          <actionDate>2018-03-07</actionDate>
          <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 341.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>House</identifiedBy>
          </item>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2018-08-14</actionDate>
        <links />
        <text>Became Public Law No: 115-234.</text>
        <type>President</type>
        <actionCode>E40000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-08-14</actionDate>
        <links />
        <text>Became Public Law No: 115-234.</text>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-08-14</actionDate>
        <links />
        <text>Signed by President.</text>
        <type>President</type>
        <actionCode>E30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-08-14</actionDate>
        <links />
        <text>Signed by President.</text>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-08-03</actionDate>
        <links />
        <text>Presented to President.</text>
        <type>Floor</type>
        <actionCode>E20000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-08-03</actionDate>
        <links />
        <text>Presented to President.</text>
        <type>President</type>
        <actionCode>28000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-08-01</actionDate>
        <committees />
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Message on Senate action sent to the House.</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2018-07-31</actionDate>
        <committees />
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Passed Senate without amendment by Voice Vote. (consideration: CR S5474)</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2018-07-31</actionDate>
        <links />
        <text>Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S5474)</text>
        <type>Floor</type>
        <actionCode>17000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-07-17</actionDate>
        <committees />
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate, read twice.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2018-07-16</actionDate>
        <actionTime>18:31:28</actionTime>
        <links />
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-07-16</actionDate>
        <actionTime>18:31:26</actionTime>
        <links />
        <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6237-6241)</text>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-07-16</actionDate>
        <actionTime>18:31:26</actionTime>
        <links />
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H6237-6241)</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-07-16</actionDate>
        <actionTime>18:25:27</actionTime>
        <links />
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 5554.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-07-16</actionDate>
        <actionTime>18:25:25</actionTime>
        <links />
        <text>Considered under suspension of the rules. (consideration: CR H6237-6242)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-07-16</actionDate>
        <actionTime>18:24:55</actionTime>
        <links />
        <text>Mr. Mullin moved to suspend the rules and pass the bill, as amended.</text>
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-05-09</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported (Amended) by Voice Vote.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2018-05-09</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2018-04-25</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2018-04-25</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Subcommittee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2018-04-25</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2018-04-18</actionDate>
        <links />
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2018-04-18</actionDate>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-04-18</actionDate>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <actionTypeCounts>
        <publicLawOrPrivateLaw>1</publicLawOrPrivateLaw>
        <becamePublicLaw>2</becamePublicLaw>
        <signedByPresidentOrSentToArchivistOfTheUnitedStatesUnsignedOrVetoedByPresidentOrPocketVetoedByPresident>1</signedByPresidentOrSentToArchivistOfTheUnitedStatesUnsignedOrVetoedByPresidentOrPocketVetoedByPresident>
        <presentedToPresident>2</presentedToPresident>
        <sentToHouse>1</sentToHouse>
        <passedSenate>1</passedSenate>
        <passedAgreedToInSenate>1</passedAgreedToInSenate>
        <introducedInSenate>1</introducedInSenate>
        <motionToReconsiderResults>1</motionToReconsiderResults>
        <finalPassageUnderSuspensionOfTheRulesResults>1</finalPassageUnderSuspensionOfTheRulesResults>
        <passedAgreedToInHouse>1</passedAgreedToInHouse>
        <generalDebate>1</generalDebate>
        <considerationByHouse>1</considerationByHouse>
        <motionMadeToSuspendTheRules>1</motionMadeToSuspendTheRules>
        <orderedToBeReported>1</orderedToBeReported>
        <committeeConsiderationMarkUp>1</committeeConsiderationMarkUp>
        <forwardedBySubcommitteeToFullCommittee>1</forwardedBySubcommitteeToFullCommittee>
        <designationOfSpeakerProTempore>1</designationOfSpeakerProTempore>
        <placeholderTextForH>1</placeholderTextForH>
        <billReferrals>1</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <actionByCounts>
        <senate>4</senate>
        <houseOfRepresentatives>14</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <sponsors>
      <item>
        <bioguideId>M001190</bioguideId>
        <fullName>Rep. Mullin, Markwayne [R-OK-2]</fullName>
        <firstName>Markwayne</firstName>
        <middleName />
        <lastName>Mullin</lastName>
        <party>R</party>
        <state>OK</state>
        <identifiers>
          <lisID>2156</lisID>
          <bioguideId>M001190</bioguideId>
          <gpoId />
        </identifiers>
        <district>2</district>
        <byRequestType />
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>S001180</bioguideId>
        <fullName>Rep. Schrader, Kurt [D-OR-5]</fullName>
        <firstName>Kurt</firstName>
        <middleName />
        <lastName>Schrader</lastName>
        <party>D</party>
        <state>OR</state>
        <identifiers>
          <lisID>1950</lisID>
          <bioguideId>S001180</bioguideId>
          <gpoId>8118</gpoId>
        </identifiers>
        <district>5</district>
        <sponsorshipDate>2018-04-18</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>W000791</bioguideId>
        <fullName>Rep. Walden, Greg [R-OR-2]</fullName>
        <firstName>GREG</firstName>
        <middleName />
        <lastName>WALDEN</lastName>
        <party>R</party>
        <state>OR</state>
        <identifiers>
          <lisID>1596</lisID>
          <bioguideId>W000791</bioguideId>
          <gpoId>8115</gpoId>
        </identifiers>
        <district>2</district>
        <sponsorshipDate>2018-04-18</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>P000034</bioguideId>
        <fullName>Rep. Pallone, Frank, Jr. [D-NJ-6]</fullName>
        <firstName>FRANK</firstName>
        <middleName />
        <lastName>PALLONE</lastName>
        <party>D</party>
        <state>NJ</state>
        <identifiers>
          <lisID>887</lisID>
          <bioguideId>P000034</bioguideId>
          <gpoId>8048</gpoId>
        </identifiers>
        <district>6</district>
        <sponsorshipDate>2018-04-18</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>B001248</bioguideId>
        <fullName>Rep. Burgess, Michael C. [R-TX-26]</fullName>
        <firstName>Michael</firstName>
        <middleName>C.</middleName>
        <lastName>Burgess</lastName>
        <party>R</party>
        <state>TX</state>
        <identifiers>
          <lisID>1751</lisID>
          <bioguideId>B001248</bioguideId>
          <gpoId>8182</gpoId>
        </identifiers>
        <district>26</district>
        <sponsorshipDate>2018-04-18</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>G000410</bioguideId>
        <fullName>Rep. Green, Gene [D-TX-29]</fullName>
        <firstName>GENE</firstName>
        <middleName />
        <lastName>GREEN</lastName>
        <party>D</party>
        <state>TX</state>
        <identifiers>
          <lisID>462</lisID>
          <bioguideId>G000410</bioguideId>
          <gpoId>8185</gpoId>
        </identifiers>
        <district>29</district>
        <sponsorshipDate>2018-04-18</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2018-06-08T16:11:00Z</pubDate>
        <title>H.R. 5554, Animal Drug and Animal Generic Drug User Fee Amendments of 2018</title>
        <url>https://www.cbo.gov/publication/53990</url>
      </item>
    </cboCostEstimates>
    <laws>
      <item>
        <type>Public Law</type>
        <number>115-234</number>
      </item>
    </laws>
    <notes />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Appropriations</name>
          </item>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Executive agency funding and structure</name>
          </item>
          <item>
            <name>Food and Drug Administration (FDA)</name>
          </item>
          <item>
            <name>Food supply, safety, and labeling</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>User charges and fees</name>
          </item>
          <item>
            <name>Veterinary medicine and animal diseases</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>49</versionCode>
          <actionDate>2018-08-14</actionDate>
          <actionDesc>Public Law</actionDesc>
          <lastSummaryUpdateDate>2019-09-18T14:54:16Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><b>Animal Drug and Animal Generic Drug User Fee Amendments of 2018</b></p> <p>TITLE I--FEES RELATING TO ANIMAL DRUGS</p> <p>This bill addresses the authority of the Food and Drug Administration (FDA)to collect new animal drug (brand name animal drug)and generic animal drug user fees.</p> <p><i>Animal Drug User Fee Amendments of 2018</i></p> <p>(Sec.103)The bill amends the Federal Food, Drug, and Cosmetic Act to reauthorize through FY2023 the authority of the FDA to collect and use brand name animal drug user fees. </p> <p>The FDA must not collect fees for (1) supplemental applications that are submitted solely to add the animal drug application number to the label of the drug, and (2) applications for genetically engineered animals that are intended to produce human medical products. </p> <p>The bill revises the total amount of revenue brand name animal drug user fees can generate. </p>  <p>The bill also revises the requirements for calculating adjustments to revenue amounts based on changes in the workload for reviewing brand name animal drug applications.</p> <p>(Sec.104)The bill extends requirements for the FDA to report to Congress on achieving goals related to the animal drug development and review processes and implementation of the authority to collect brand name animal drug user fees. </p> <p>(Sec.107)The bill terminates the authority of the FDA to collect brand name animal drug user fees on October 1, 2023. </p> <p>TITLE II--FEES RELATING TO GENERIC ANIMAL DRUGS</p> <p><i>Animal Generic Drug User Fee Amendments of 2018</i></p> <p>(Sec.202)The bill reauthorizes through FY2023 the authority of the FDA to collect and use generic animal drug user fees.The FDA must not collect fees for supplemental abbreviated applications that are submitted solely to add the generic animal drug application number to the label of the drug.</p> <p> The bill revises the total amount of revenue each type of generic animal drug user fee must generate. </p> <p>The bill also revises the requirements for calculating adjustments to revenue amounts based on changes in the workload for reviewing generic animal drug applications.</p> <p>(Sec.203)The bill extends requirements for the FDA to report to Congress on achieving goals related to the generic animal drug development and review process and the implementation of the authority to collect generic animal drug fees. </p> <p>(Sec.206)The bill terminates the authority of the FDA to collect generic animal drug user fees on October 1, 2023. </p> <p>TITLE III--MISCELLANEOUS PROVISIONS</p> <p>(Sec.301)Brand name and generic animal drug applications must be submitted electronically beginning in FY2019. Additionally, applications for conditional approval of brand name animal drugs for minor use and minor species must be submitted electronically beginning in FY2019. (Minor use drugs are for intended uses in major species [horses, dogs, cats, cattle, pigs, turkeys, and chickens] for diseases that occur infrequently or in limited geographic areas and in only a small number of animals annually.)</p> <p>(Sec.302)Product labeling for certain unapproved brand name animal drugs for minor species must include the index number in order to be marketed.</p> <p>(Sec.303)The bill prohibits the sale of brand name animal drugs that do not include the FDA application number.</p> <p>(Sec.304)The bill authorizes the FDA to grant conditional approval of a brand name animal drug not intended for a minor use or minor species if (1) the drug is intended to treat a serious or life-threatening disease or condition or addresses an unmet animal or human health need, and (2) the FDA determines that a demonstration of effectiveness of the drug would require a complex or particularly difficult study or studies. </p> <p>The FDA must issue guidance or regulations that provide further details regarding the criteria for conditional approval. </p> <p>The bill terminates this conditional approval authority on October 1, 2028.</p> <p>The Government Accountability Office must study the effects of the conditional approval pathway for brand name animal drugs. </p> <p>(Sec.305)The FDA must issue guidance on how to evaluate certain elements of investigations as part of the animal drug application process, and how drug sponsors may obtain feedback from the agency on technical issues before submitting an application. </p> <p>(Sec.306)The FDA must review investigations conducted in foreign countries when acting on a petition for a food additive intended for use in animal food. </p> <p>The FDA must also issue guidance on the voluntary pre-petition consultation process for such food additives.</p>]]></text>
          <updateDate>2018-08-15T03:59:58Z</updateDate>
          <name>Public Law</name>
        </item>
      </billSummaries>
    </summaries>
    <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2018</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2018</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Titles as Passed House for portions of this bill</titleType>
        <parentTitleType>Short Titles House of Representatives</parentTitleType>
        <title>Animal Drug User Fee Amendments of 2018</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Passed Senate for portions of this bill</titleType>
        <parentTitleType>Short Titles Senate</parentTitleType>
        <title>Animal Generic Drug User Fee Amendments of 2018</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Passed Senate for portions of this bill</titleType>
        <parentTitleType>Short Titles Senate</parentTitleType>
        <title>Animal Drug User Fee Amendments of 2018</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Enacted for portions of this bill</titleType>
        <parentTitleType>Short Title</parentTitleType>
        <title>Animal Generic Drug User Fee Amendments of 2018</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Titles as Enacted for portions of this bill</titleType>
        <parentTitleType>Short Title</parentTitleType>
        <title>Animal Drug User Fee Amendments of 2018</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Titles as Introduced for portions of this bill</titleType>
        <parentTitleType />
        <title>Animal Generic Drug User Fee Amendments of 2018</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Titles as Introduced for portions of this bill</titleType>
        <parentTitleType />
        <title>Animal Drug User Fee Amendments of 2018</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Titles as Passed House for portions of this bill</titleType>
        <parentTitleType>Short Titles House of Representatives</parentTitleType>
        <title>Animal Generic Drug User Fee Amendments of 2018</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2018</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Titles as Passed House</titleType>
        <parentTitleType>Short Titles House of Representatives</parentTitleType>
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2018</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Passed Senate</titleType>
        <parentTitleType>Short Titles Senate</parentTitleType>
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2018</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Enacted</titleType>
        <parentTitleType>Short Title</parentTitleType>
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2018</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>To amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs.</title>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <amendments />
    <textVersions>
      <item>
        <type>Enrolled Bill</type>
        <date />
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr5554enr/xml/BILLS-115hr5554enr.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Received in Senate</type>
        <date>2018-07-17T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr5554rds/xml/BILLS-115hr5554rds.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Engrossed in House</type>
        <date>2018-07-16T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr5554eh/xml/BILLS-115hr5554eh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2018-04-18T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr5554ih/xml/BILLS-115hr5554ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2018-08-14</actionDate>
      <text>Became Public Law No: 115-234.</text>
      <links />
    </latestAction>
    <calendarNumbers />
    <version>1.0.0</version>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

